Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
Berdeja, Jesus G, Hart, Lowell L, Mace, Joseph R, Arrowsmith, Edward R, Essell, James H, Owera, Rami S, Hainsworth, John D, Flinn, Ian W
Published in Haematologica (Roma) (01.05.2015)
Published in Haematologica (Roma) (01.05.2015)
Get full text
Journal Article
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920
Emamekhoo, Hamid, Olsen, Mark R., Carthon, Bradley C., Drakaki, Alexandra, Percent, Ivor J., Molina, Ana M., Cho, Daniel C., Bendell, Johanna C., Gordan, Lucio N., Rezazadeh Kalebasty, Arash, George, Daniel J., Hutson, Thomas E., Arrowsmith, Edward R., Zhang, Joshua, Zoco, Jesus, Johansen, Jennifer L., Leung, David K., Tykodi, Scott S.
Published in Cancer (01.03.2022)
Published in Cancer (01.03.2022)
Get full text
Journal Article
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion cohort
Berdeja, Jesus G., Gregory, Tara K., Faber, Edward A., Hart, Lowell L., Mace, Joseph R., Arrowsmith, Edward R., Flinn, Ian W., Matous, Jeffrey V.
Published in American journal of hematology (01.04.2021)
Published in American journal of hematology (01.04.2021)
Get full text
Journal Article
Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
NG, Kimmie, TABERNERO, Josep, MALEK, Kamel, FUCHS, Charles S, HWANG, Jimmy, BAJETTA, Emilio, SHARMA, Sunil, DEL PRETE, Salvatore A, ARROWSMITH, Edward R, RYAN, David P, SEDOVA, Michaela, JIN JIN
Published in Clinical cancer research (15.07.2013)
Published in Clinical cancer research (15.07.2013)
Get full text
Journal Article
A Phase II Study with Lead‐In Safety Cohort of 5‐Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2‐Positive Esophagogastric Adenocarcinomas
Shepard, Gregg, Arrowsmith, Edward R., Murphy, Patrick, Barton, John H., Peyton, James D., Mainwaring, Mark, Blakely, Laura, Maun, Noel A., Bendell, Johanna C.
Published in The oncologist (Dayton, Ohio) (01.10.2017)
Published in The oncologist (Dayton, Ohio) (01.10.2017)
Get full text
Journal Article
A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma
Hainsworth, John D., Infante, Jeffrey R., Spigel, David R., Arrowsmith, Edward R., Boccia, Ralph V., Burris, Howard A.
Published in Cancer investigation (01.08.2011)
Published in Cancer investigation (01.08.2011)
Get full text
Journal Article
A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma
Hainsworth, John D., Arrowsmith, Edward R., McCleod, Michael, Hsi, Eric D., Hamid, Oday, Shi, Peipei, Lin, Boris K., Fayad, Luis E.
Published in Leukemia & lymphoma (02.01.2016)
Published in Leukemia & lymphoma (02.01.2016)
Get full text
Journal Article
A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia
Donnellan, William, Berdeja, Jesus G., Shipley, Diana, Arrowsmith, Edward R., Wright, David, Lunin, Scott, Brown, Richard, Essell, James H., Flinn, Ian W.
Published in The oncologist (Dayton, Ohio) (01.10.2017)
Published in The oncologist (Dayton, Ohio) (01.10.2017)
Get full text
Journal Article
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer
Yardley, Denise A., Arrowsmith, Edward R., Daniel, Brooke R., Eakle, Janice, Brufsky, Adam, Drosick, David R., Kudrik, Fred, Bosserman, Linda D., Keaton, Mark R., Goble, Sharon A., Bubis, Jeffrey A., Priego, Victor M., Pendergrass, Kelly, Manalo, Yvonne, Bury, Martin, Gravenor, Donald S., Rodriguez, Gladys I., Inhorn, Roger C., Young, Robyn R., Harwin, William N., Silver, Caryn, Hainsworth, John D., Burris, Howard A.
Published in Breast cancer research and treatment (01.08.2017)
Published in Breast cancer research and treatment (01.08.2017)
Get full text
Journal Article
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
Hainsworth, John D., Reeves, James A., Mace, Joseph R., Crane, Edward J., Hamid, Oday, Stille, John R., Flynt, Amy, Roberson, Stephanie, Polzer, John, Arrowsmith, Edward R.
Published in Targeted oncology (01.10.2016)
Published in Targeted oncology (01.10.2016)
Get full text
Journal Article
Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial
Hainsworth, John D, Rubin, Mark S, Arrowsmith, Edward R, Khatcheressian, James, Crane, Edward J, Franco, Luis A
Published in Clinical genitourinary cancer (01.09.2013)
Published in Clinical genitourinary cancer (01.09.2013)
Get full text
Journal Article
Everolimus in combination with paclitaxel and carboplatin in patients with metastatic melanoma: a phase II trial of the Sarah Cannon Research Institute Oncology Research Consortium
Hauke, Ralph J, Infante, Jeffrey R, Rubin, Mark S, Shih, Kent C, Arrowsmith, Edward R, Hainsworth, John D
Published in Melanoma research (01.12.2013)
Published in Melanoma research (01.12.2013)
Get more information
Journal Article
High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium
Hainsworth, John D, Shipley, Dianna L, Reeves, James, Arrowsmith, Edward R, Barnes, Edward K, Waterhouse, David M
Published in Clinical genitourinary cancer (01.09.2013)
Published in Clinical genitourinary cancer (01.09.2013)
Get full text
Journal Article
A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer
Spigel, David R, Greco, F. Anthony, Burris, Howard A, Shipley, Dianna L, Clark, Bobby L, Whorf, Robert C, Arrowsmith, Edward R, Hainsworth, John D
Published in Clinical lung cancer (01.05.2011)
Published in Clinical lung cancer (01.05.2011)
Get full text
Journal Article
Peripheral T-cell Lymphomas: Clinical Features and Prognostic Factors of 92 Cases Defined by the Revised European American Lymphoma Classification
Arrowsmith, Edward R., Macon, William R., Kinney, Marsha C., Stein, Richard S., Goodman, Stacey A., Morgan, David S., Flexner, John M., Cousar, John B., Jagasia, Madan H., McCurley, Thomas L., Greer, John P.
Published in Leukemia & lymphoma (01.01.2003)
Published in Leukemia & lymphoma (01.01.2003)
Get full text
Journal Article
A Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Final Analysis of Second Dose Expansion
Berdeja, Jesus G., Gregory, Tara B., Faber, Edward, Matous, Jeffrey, Hart, Lowell, Mace, Joseph R., Arrowsmith, Edward R., Flinn, Ian W.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
A Phase I/II Study of the Combination of Panobinostat (PAN) and Carfilzomib (CFZ) in Patients (pts) with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Comparison of Two Expansion Cohorts
Berdeja, Jesus G., Gregory, Tara B., Faber, Edward A., Matous, Jeffrey V., Hart, Lowell L., Mace, Joseph R., Peyton, James D., Essell, James H., Arrowsmith, Edward R., Flinn, Ian W.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Advanced-Practice Nursing -- Good Medicine for Physicians?
Buechler, James R, Blankenship, James C, Weinberg, Nolan L, Arrowsmith, Edward R, Wartman, Steven A, Mundinger, Mary O
Published in The New England journal of medicine (26.05.1994)
Published in The New England journal of medicine (26.05.1994)
Get full text
Journal Article